Influence of a patient training on the reliability for medication intake and for the further course of disease by patients with ulcerative colitis

Not Applicable

• Conditions: K51.0; K51; Ulcerative colitis

• Registration Number: DRKS00008905
• Lead Sponsor: Kompetenznetz Darmerkrankungen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2013-12-12
• Study Start: 2015-07-14
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 247

Inclusion Criteria

Age = 18 years
- Diagnostic of ulcerative colitis (histologically confirmed or by a coloscopy) = 2 years
- Ulcerative colitis in remission phase or with a low or moderate disease activity.
- Regular intake of a mesalazine preparation in a dose of 1,2 - 4,8 g/d
- Availability of a written agreement to participate in the study.

Exclusion Criteria

- Acute ulcerative colitis
- Mesalazine intolerance
- Colektomy
- Ileostoma

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Difference between study arms by baseline and one year after executed advanced training in the Morisky Medication Adherence Scale regarding the medication intake. <br>

Secondary Outcome Measures

Name	Time	Method
- Examination of the life quality obtained by IBDQ-D by baseline and one year after performed advanced training.<br>- Examination of the course of the disease obtained by CAI by baseline and one year after performed advanced training.<br>- Examination of the White-Coat-Compliance based on the proven 5-ASA urin measurement by baseline and one year after performed advanced training.